J. Goldman & Co’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-150,611
| Closed | -$562K | – | 512 |
|
|
2024
Q3 | $562K | Sell |
150,611
-40,500
| -21% | -$151K | 0.02% | 237 |
|
|
2024
Q2 | $1.07M | Sell |
191,111
-67,585
| -26% | -$378K | 0.03% | 200 |
|
|
2024
Q1 | $1.36M | Buy |
258,696
+12,271
| +5% | +$64.3K | 0.04% | 170 |
|
|
2023
Q4 | $1.29M | Buy |
+246,425
| New | +$1.29M | 0.05% | 141 |
|
|
2022
Q1 | – | Sell |
-75,646
| Closed | -$3.85M | – | 360 |
|
|
2021
Q4 | $3.85M | Buy |
75,646
+47,118
| +165% | +$2.4M | 0.21% | 92 |
|
|
2021
Q3 | $1.59M | Buy |
+28,528
| New | +$1.59M | 0.08% | 154 |
|
|
2016
Q2 | – | Sell |
-1,700
| Closed | -$69K | – | 301 |
|
|
2016
Q1 | $69K | Buy |
+1,700
| New | +$69K | ﹤0.01% | 179 |
|